Start with the documented link between the container and the analytical record
Record the product identifier and lot code from the container label, then locate the corresponding lot on the COA and relevant delivery records. If an invoice does not carry a lot code, a packing list or another controlled supplier record may provide the link.
A chromatogram sample name need not reproduce the supplier lot code character for character. Laboratories may use internal sample identifiers, preparation numbers or aliquot codes. What matters is a documented, unambiguous mapping from the reported result to the sample and from that sample to the supplied lot. A generic name such as Sample-1 is insufficient on its own, but may be traceable through a sample register or sequence record.
Useful supporting fields include the report identifier, analysis date, analytical method and version, sample identifier and authorisation details. Instrument, sequence and chromatography-data-system result identifiers may appear in supporting records rather than on the COA itself. An acquisition method describes how data were collected; a processing method describes how those data were handled. One method identifier does not necessarily cover both.
An analysis date helps establish chronology, but cannot by itself prove that a chromatogram represents the supplied lot. Where identifiers differ, request the mapping before treating the result as evidence for that container. Keep the explanation with the receiving record rather than relying on an informal assurance.
Read the chromatogram with its method and reporting context
An HPLC chromatogram plots detector response against chromatographic time. For UV detection, the response may be reported in absorbance units or milli-absorbance units, with a stated wavelength. Other detectors use different response units. Check the detector channel, axis labels, run window and sample identifier before interpreting the main peak.
Ask whether the available records identify the column, mobile-phase programme and relevant acquisition and processing conditions sufficiently for the intended review. Blank runs, reference materials and system-suitability results may be provided separately. Their absence from a one-page COA is not proof that they were omitted from the analysis.
A cropped or compressed display can conceal useful information. If the run window or scale prevents review, request a more informative export and the associated peak table. A peak extending beyond the displayed axis does not necessarily mean the detector was saturated: display clipping and detector saturation are different issues and require clarification.
Labels such as main peak, related substance and unidentified peak describe how responses were assigned. They do not independently prove chemical identity. Co-eluting components may appear as one peak, and substances with little or no response under the selected conditions may not be represented meaningfully. A clean-looking trace therefore does not establish complete composition, identity or suitability for use.
Reconcile the reported percentage with the calculation actually used
First determine what the reported result means. HPLC reports may use area normalisation, calibration against a reference material, response-factor corrections or another defined calculation. Do not assume that every percentage labelled purity is a main-peak area percentage.
For an uncorrected area-normalisation calculation, main-peak area percentage equals the main-peak area divided by the sum of included peak areas, multiplied by 100. For example, a main-peak area of 980 units and other included areas totalling 20 units gives 98.0% main-peak area. That result describes the included detector responses under the stated conditions; it is not automatically 98.0% peptide by mass.
Check which peaks enter the denominator. Blank-related responses, system peaks and other exclusions should be handled according to the method, not removed simply because they are inconvenient. Reporting thresholds and integration rules also affect the presentation. Peaks classified as sample-related and included by the method should not be silently removed to increase the main-peak percentage.
A complete area-normalised table using a common denominator should total approximately 100%, allowing for rounding. A related-substances-only table, a table reporting only selected peaks or a response-factor-corrected presentation may not. An unexpected total is a reason to clarify the calculation and table scope, not automatic proof that the analysis is invalid.
Peak height and peak area are not interchangeable. Results at different wavelengths may also differ because components respond differently. Record the detector conditions and calculation basis before comparing reports. Chromatographic area percentage is distinct from net peptide content, water content, counter-ion content and other separately determined attributes.
Use RRT rows for peak tracking, not standalone identification
Relative retention time (RRT) is commonly calculated by dividing a peak's retention time by that of a specified reference peak in the same run. The reference is often the main peak, but the report or method should identify it. Some methods use adjusted retention times, so confirm the definition before recalculating a value.
RRT can help track peaks within a suitably controlled method. It is not a universal fingerprint: column chemistry, gradient conditions, temperature and other method differences can alter relative retention. Matching RRT values across unrelated supplier methods does not establish that two peaks are the same substance. The absence of an RRT column is not, by itself, a lot-traceability failure.
An unidentified row records a response that has not been assigned a supported chemical identity. A named impurity should have an appropriate evidential basis, which might include an authenticated reference material, co-injection, mass spectrometry or other characterisation. A matching mass alone may not distinguish isomers or establish sequence, and the absence of an attached mass spectrum does not prove that an assignment lacks support.
Interpret unidentified peaks against the method's reporting rules and the laboratory's agreed specifications. Their number alone does not determine whether a lot passes. Relevant system-suitability checks are method-specific and may include resolution of a critical pair, repeatability, sensitivity or peak shape. No single list applies to every HPLC procedure.
Build a receiving checklist around traceability and agreed requirements
Before ordering, agree which records the supplier will provide and which acceptance criteria apply to the intended research work. A routine COA may not include complete chromatograms, raw files or every system-suitability result. If those records are required, establish their availability in advance.
At receipt, record the product and lot identifiers, receiving date, document versions and any internal sample mapping. Check that the report covers the relevant lot and that the reported results meet the agreed specifications. Where separate chromatograms or analytical reports are supplied, confirm that their identifiers and method references reconcile with the COA or have a documented explanation.
If mass-spectrometry results are included, interpret the stated species, charge state, adduct and mass convention before comparing the result with a molecular-mass specification. A simple numerical comparison can be misleading when those conventions differ. Seek analytical review where identity evidence is material to the acceptance decision.
Document availability should be assessed independently of dispatch location or tracking. Australian stock and tracked delivery do not establish analytical quality or guarantee access to batch records. This article makes no unverified claim about a particular supplier's stock, dispatch service or documentation pack.
A practical receiving checklist records: container-to-lot linkage; COA and supporting-report identifiers; sample-to-lot mapping where needed; method and calculation basis; results against agreed specifications; outstanding questions; and the authorised receipt or release decision.
Which documentation gaps warrant clarification or a hold?
An unresolved link between the supplied container and the reported lot is a significant traceability concern. Conflicting report versions, unexplained result changes, a calculation that cannot be reconciled or missing evidence required by the laboratory's procedure may also justify a hold pending investigation.
Other gaps require context. A missing chromatogram limits independent review but does not automatically invalidate a COA. An internal sample code differing from the vial lot may be acceptable with a controlled mapping. An absent handwritten signature may be covered by a valid electronic authorisation process. A result identifier may point to a processed report without giving the recipient direct access to raw data.
Use the laboratory's documented process to decide whether to request clarification, quarantine the material, reject it or accept it following authorised review. Material can be recorded as received while remaining unavailable for use; receipt into a quarantine inventory is different from release to research work.
Lot acceptance is not solely a paperwork exercise. Depending on the intended research and agreed requirements, container integrity, transport and storage records, analytical suitability and other checks may also matter. Retain supplier responses and replacement documents with version control so the final decision remains auditable. Nothing in this process authorises human or animal administration.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
What should be checked first on a peptide COA?
Start with the link between the container's product and lot identifiers and the COA. Then check that supporting analytical sample identifiers either match or have a documented mapping to that lot. A high reported percentage cannot replace this traceability check.
Must the chromatogram sample name exactly match the vial lot code?
Not necessarily. An internal laboratory sample code can be acceptable if controlled records unambiguously link it to the supplied lot. An unexplained mismatch should be resolved before relying on the chromatogram for that container.
Does a high HPLC area percentage prove identity or peptide content?
No. It describes the proportion of included detector response attributed to a peak under a particular method. It does not independently establish identity, mass fraction, complete composition or suitability for administration.
What if a supplier provides a percentage without a chromatogram?
You cannot independently reconstruct or assess that result from the percentage alone. Request the calculation basis and supporting records required by your procurement agreement and laboratory procedure. Whether their absence prevents acceptance depends on those requirements and the intended research.
Can RRT values be compared between suppliers?
Only with appropriate method context. RRT may assist peak tracking under comparable, controlled conditions, but the same value across different methods does not establish the same impurity. Ask what reference peak and calculation convention were used.
Does research-use-only labelling or a COA establish TGA approval?
No. Neither research-use-only labelling nor analytical documentation establishes TGA approval, lawful therapeutic supply or safety for human or animal administration. This guide addresses laboratory documentation only.
What documents should accompany a research-material delivery?
The documents agreed with the supplier and required by the receiving laboratory. These commonly include lot-linked product and delivery records and a COA; chromatograms, peak tables and additional analytical reports may be supplied separately. Confirm requirements before ordering rather than assuming tracked dispatch includes them.
References
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
- DOI:10.1006/abio.1993.1102 — The Direct Assay of Kinases and Acyl-CoA Synthetases by HPLC: Application to Nucleoside Diphosphate Kinase and Succinyl-CoA Synthetase — Analytical Biochemistry — 1993
- DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
- DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
- DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995
- DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
